Tumor Volume Estimation and Quasi-Continuous Administration for Most Effective Bevacizumab Therapy
BACKGROUND: Bevacizumab is an exogenous inhibitor which inhibits the biological activity of human VEGF. Several studies have investigated the effectiveness of bevacizumab therapy according to different cancer types but these days there is an intense debate on its utility. We have investigated different methods to find the best tumor volume estimation since it creates the possibility for precise and effective drug administration with a much lower dose than in the protocol. MATERIALS AND METHODS:
Record details
Published: 5 November 2015
Source: OpenAlex
Category: Research
Topics: Healthcare · Finance, VC & PE · Biotech
Retrieved: 14 July 2026
Related evidence
These records share source-supplied organisations, an exact publisher byline, automatic topics or regions. The reason is shown on every link; related does not mean supporting, agreeing with or verifying this record.
FDA-ARGOS is a database with public quality-controlled reference genomes for diagnostic use and regulatory science
OpenAlex · 25 July 2019
A multi-omics approach unravels metagenomic and metabolic alterations of a probiotic and synbiotic additive in rainbow trout (Oncorhynchus mykiss)
OpenAlex · 30 January 2022
Artificial intelligence alphafold model for molecular biology and drug discovery: a machine-learning-driven informatics investigation
OpenAlex · 5 October 2024
Explainable Multi-Task Retinal Imaging Reveals Microvascular Signals for Systemic Risk Stratification in Type 2 Diabetes: A Pilot Study
arXiv · 24 May 2026
CellPrism: A Visual Analytics System for Exploring AI-Driven Virtual Cells in Drug Discovery
arXiv cs.HC · 3 August 2026
Social Media Influencer Marketing as a Clinical Trial Recruitment Modality: Tutorial Informed by One Study’s Approach
JMIR (Journal of Medical Internet Research) · 11 August 2026
How to cite this record
ethics.ai (5 November 2015), “Tumor Volume Estimation and Quasi-Continuous Administration for Most Effective Bevacizumab Therapy,” evidence record 7712, https://ethics.ai/record/7712 (originally published by OpenAlex).
Use and limitations
This page is a stable index and citation surface for a source record. ethics.ai did not author the underlying report and has not independently verified every claim. Automatic topics may be imperfect. For consequential use, quote and cite the original publisher.